指南与共识重症综合管理与镇静镇痛心脑血管急症

神经重症患者的液体治疗:ESICM共识与临床实践推荐

Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations.
指南 / 共识 · Intensive Care Med · 2018-03-02
一句话结论ESICM发布神经重症液体治疗共识,共32条陈述,含13条强推荐和17条弱推荐,聚焦复苏与维持、高渗液体控制颅内压及蛛网膜下腔出血后迟发性脑缺血。

ESICM于2016年10月组建22名国际专家的共识委员会,针对神经重症患者液体治疗提出PICO问题并生成证据概要,聚焦三大主题:一般液体复苏与维持、高渗液体控制颅内压、蛛网膜下腔出血后迟发性脑缺血的液体管理。采用GRADE系统评估证据质量(高至极低),将推荐分为强推荐或弱推荐,并在适用时发布最佳实践声明;同时采用改良Delphi流程整合文献证据与专家意见。最终共识共32条陈述,包括13条强推荐和17条弱推荐,2条陈述未提供推荐。

要点

  • 共识覆盖三大主题:神经重症一般液体复苏与维持、高渗液体控制颅内压、蛛网膜下腔出血后迟发性脑缺血液体管理。
  • 最终共识共32条陈述,其中13条强推荐、17条弱推荐,2条陈述未提供推荐。
  • 方法学采用GRADE系统评估证据质量(高至极低),推荐强度分为强推荐或弱推荐。
  • 共识委员会由22名国际专家组成,2016年10月于ESICM LIVES2016会议期间召开会议。
  • 采用改良Delphi流程整合文献证据与专家意见,以序贯方式避免偏倚和误读。

适用人群与场景

  • 神经重症监护患者,涵盖一般液体复苏与维持、颅内压控制及蛛网膜下腔出血后迟发性脑缺血三个主题所涉及的人群。

研究设计与关键结果

  • 制定机构为ESICM,共识委员会由22名国际专家组成,于2016年10月ESICM LIVES2016会议期间召开会议,并通过电话会议和电子讨论推进共识流程。
  • 方法学:针对PICO问题复习并更新证据概要,采用GRADE系统评估证据质量(高至极低),将推荐分为强推荐或弱推荐,适用时发布最佳实践声明。
  • 采用改良Delphi流程,整合文献证据与专家意见,以序贯方式避免偏倚和误读,生成最终共识陈述。
  • 最终共识共32条陈述,包括13条强推荐和17条弱推荐;2条陈述未提供推荐。

证据类型、等级与局限

  • 证据类型:ESICM共识与临床实践推荐(指南/共识)。
  • 证据分级体系:GRADE系统,证据质量从高至极低,推荐强度分为强推荐或弱推荐。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐

指南或共识出处

  • ESICM共识与临床实践推荐:神经重症监护患者液体治疗(Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations),发布机构ESICM,发表于Intensive Care Med。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To report the ESICM consensus and clinical practice recommendations on fluid therapy in neurointensive care patients.

DESIGN: A consensus committee comprising 22 international experts met in October 2016 during ESICM LIVES2016. Teleconferences and electronic-based discussions between the members of the committee subsequently served to discuss and develop the consensus process.

METHODS: Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles generated. The consensus focused on three main topics: (1) general fluid resuscitation and maintenance in neurointensive care patients, (2) hyperosmolar fluids for intracranial pressure control, (3) fluid management in delayed cerebral ischemia after subarachnoid haemorrhage. After an extensive literature search, the principles of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system were applied to assess the quality of evidence (from high to very low), to formulate treatment recommendations as strong or weak, and to issue best practice statements when applicable. A modified Delphi process based on the integration of evidence provided by the literature and expert opinions-using a sequential approach to avoid biases and misinterpretations-was used to generate the final consensus statement.

RESULTS: The final consensus comprises a total of 32 statements, including 13 strong recommendations and 17 weak recommendations. No recommendations were provided for two statements.

CONCLUSIONS: We present a consensus statement and clinical practice recommendations on fluid therapy for neurointensive care patients.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Oddo M, Poole D, Helbok R, et al. Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations. Intensive Care Med. 2018. PMID: 29500701. doi:10.1007/s00134-018-5086-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。